SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-031810
Filing Date
2019-08-13
Accepted
2019-08-13 16:21:56
Documents
57
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q acer-10q_20190630.htm 10-Q 1485987
2 EX-10.1 acer-ex101_138.htm EX-10.1 35729
3 EX-31.1 acer-ex311_6.htm EX-31.1 17837
4 EX-31.2 acer-ex312_7.htm EX-31.2 17510
5 EX-32.1 acer-ex321_9.htm EX-32.1 7892
6 EX-32.2 acer-ex322_8.htm EX-32.2 7691
7 GRAPHIC gt4nflsngegp000001.jpg GRAPHIC 1836
8 GRAPHIC glctkh45dsvc000002.jpg GRAPHIC 14437
9 GRAPHIC glctkh45dsvc000001.jpg GRAPHIC 18134
  Complete submission text file 0001564590-19-031810.txt   4497187

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT acer-20190630.xml EX-101.INS 710371
11 XBRL TAXONOMY EXTENSION SCHEMA acer-20190630.xsd EX-101.SCH 35475
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acer-20190630_cal.xml EX-101.CAL 35761
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acer-20190630_def.xml EX-101.DEF 101284
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE acer-20190630_lab.xml EX-101.LAB 318262
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acer-20190630_pre.xml EX-101.PRE 220616
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33004 | Film No.: 191020919
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences